Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study
Emerging Classic

Key potentially inappropriate drugs in pediatrics: the KIDs list.

Meyers RS, Thackray J, Matson KL, et al. Key potentially inappropriate drugs in pediatrics: the KIDs list. J Pediatr Pharmacol Ther. 2020;25(3):175-191. Epub 2020/04/09. doi: 10.5863/1551-6776-25.3.175. 

Save
Print
June 24, 2020
Meyers RS, Thackray J, Matson KL, et al. J Pediatr Pharmacol Ther. 2020;25(3).
View more articles from the same authors.

This article describes the development of the Key Potentially Inappropriate Drugs in Pediatrics, or “KIDs” List, intended to create a standard of care for safe medication use in pediatric populations. A panel of seven pediatric pharmacists from the Pediatric Pharmacy Association developed an evidence-based list of candidate drugs which was then peer-reviewed and subjected to a public comment period. The final KIDs List includes 67 drugs/drug classes; most require a prescription and are available in various dosage formulations.

Save
Print
Cite
Citation

Meyers RS, Thackray J, Matson KL, et al. Key potentially inappropriate drugs in pediatrics: the KIDs list. J Pediatr Pharmacol Ther. 2020;25(3):175-191. Epub 2020/04/09. doi: 10.5863/1551-6776-25.3.175. 

Related Resources From the Same Author(s)
Related Resources